Antibodies generated in humans to DENV are of particular clinical relevance, because they have the potential
during a subsequent infection to protect from or increase the risk of developing DHF.
If you have already given birth to a baby who had a serious case of congenital CMV
infection, your future pregnancies will most likely not be affected — CMV
infection usually results from a first - time exposure to CMV
during pregnancy only and it is extremely rare for a
subsequent pregnancy to be affected.